Turning Point Therapeutics, Inc. EBITDA Margin 2019-2022 | TPTX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Turning Point Therapeutics, Inc. (TPTX) over the last 10 years. The current EBITDA margin for Turning Point Therapeutics, Inc. as of June 30, 2022 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2022-06-30 | $0.00B | $-0.34B | inf% |
| 2022-03-31 | $0.01B | $-0.27B | -5340.00% |
| 2021-12-31 | $0.03B | $-0.23B | -760.00% |
| 2021-06-30 | $0.06B | $-0.15B | -276.36% |
